img

Global Scopolamine Transdermal Patch Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Scopolamine Transdermal Patch Market Insights, Forecast to 2034

Scopolamine is used to prevent nausea and vomiting caused by motion sickness or medications used during surgery. Scopolamine is in a class of medications called antimuscarinics. It works by blocking the effects of a certain natural substance (acetylcholine) on the central nervous system.
Global Scopolamine Transdermal Patch market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Scopolamine Transdermal Patch industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Global Scopolamine market is projected to reach US$ 15 million in 2029, increasing from US$ 11 million in 2022, with the CAGR of 4.2% during the period of 2024 to 2029. Demand from Tablets and Injection are the major drivers for the industry.
Report Covers
This report presents an overview of global Scopolamine Transdermal Patch market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Scopolamine Transdermal Patch market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Perrigo
Baxter
GSK
Mylan
Novartis
BengbuBBCATushan Pharmaceutical Co
Segment by Type
1mg
1.5mg

Segment by Application


Motion Sickness
Nausea/Vomiting
Parkinsonian Tremor
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Scopolamine Transdermal Patch plant distribution, commercial date of Scopolamine Transdermal Patch, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Scopolamine Transdermal Patch introduction, etc. Scopolamine Transdermal Patch Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Scopolamine Transdermal Patch
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Scopolamine Transdermal Patch Product Introduction
1.2 Market by Type
1.2.1 Global Scopolamine Transdermal Patch Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 1mg
1.2.3 1.5mg
1.3 Market by Application
1.3.1 Global Scopolamine Transdermal Patch Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Motion Sickness
1.3.3 Nausea/Vomiting
1.3.4 Parkinsonian Tremor
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Scopolamine Transdermal Patch Sales Estimates and Forecasts 2018-2029
2.2 Global Scopolamine Transdermal Patch Revenue by Region
2.2.1 Global Scopolamine Transdermal Patch Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Scopolamine Transdermal Patch Revenue by Region (2018-2024)
2.2.3 Global Scopolamine Transdermal Patch Revenue by Region (2024-2029)
2.2.4 Global Scopolamine Transdermal Patch Revenue Market Share by Region (2018-2029)
2.3 Global Scopolamine Transdermal Patch Sales Estimates and Forecasts 2018-2029
2.4 Global Scopolamine Transdermal Patch Sales by Region
2.4.1 Global Scopolamine Transdermal Patch Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Scopolamine Transdermal Patch Sales by Region (2018-2024)
2.4.3 Global Scopolamine Transdermal Patch Sales by Region (2024-2029)
2.4.4 Global Scopolamine Transdermal Patch Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Scopolamine Transdermal Patch Sales by Manufacturers
3.1.1 Global Scopolamine Transdermal Patch Sales by Manufacturers (2018-2024)
3.1.2 Global Scopolamine Transdermal Patch Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Scopolamine Transdermal Patch in 2022
3.2 Global Scopolamine Transdermal Patch Revenue by Manufacturers
3.2.1 Global Scopolamine Transdermal Patch Revenue by Manufacturers (2018-2024)
3.2.2 Global Scopolamine Transdermal Patch Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Scopolamine Transdermal Patch Revenue in 2022
3.3 Global Key Players of Scopolamine Transdermal Patch, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Scopolamine Transdermal Patch Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Scopolamine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Scopolamine Transdermal Patch, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Scopolamine Transdermal Patch, Product Offered and Application
3.8 Global Key Manufacturers of Scopolamine Transdermal Patch, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Scopolamine Transdermal Patch Sales by Type
4.1.1 Global Scopolamine Transdermal Patch Historical Sales by Type (2018-2024)
4.1.2 Global Scopolamine Transdermal Patch Forecasted Sales by Type (2024-2029)
4.1.3 Global Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
4.2 Global Scopolamine Transdermal Patch Revenue by Type
4.2.1 Global Scopolamine Transdermal Patch Historical Revenue by Type (2018-2024)
4.2.2 Global Scopolamine Transdermal Patch Forecasted Revenue by Type (2024-2029)
4.2.3 Global Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
4.3 Global Scopolamine Transdermal Patch Price by Type
4.3.1 Global Scopolamine Transdermal Patch Price by Type (2018-2024)
4.3.2 Global Scopolamine Transdermal Patch Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Scopolamine Transdermal Patch Sales by Application
5.1.1 Global Scopolamine Transdermal Patch Historical Sales by Application (2018-2024)
5.1.2 Global Scopolamine Transdermal Patch Forecasted Sales by Application (2024-2029)
5.1.3 Global Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
5.2 Global Scopolamine Transdermal Patch Revenue by Application
5.2.1 Global Scopolamine Transdermal Patch Historical Revenue by Application (2018-2024)
5.2.2 Global Scopolamine Transdermal Patch Forecasted Revenue by Application (2024-2029)
5.2.3 Global Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
5.3 Global Scopolamine Transdermal Patch Price by Application
5.3.1 Global Scopolamine Transdermal Patch Price by Application (2018-2024)
5.3.2 Global Scopolamine Transdermal Patch Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Scopolamine Transdermal Patch Market Size by Type
6.1.1 US & Canada Scopolamine Transdermal Patch Sales by Type (2018-2029)
6.1.2 US & Canada Scopolamine Transdermal Patch Revenue by Type (2018-2029)
6.2 US & Canada Scopolamine Transdermal Patch Market Size by Application
6.2.1 US & Canada Scopolamine Transdermal Patch Sales by Application (2018-2029)
6.2.2 US & Canada Scopolamine Transdermal Patch Revenue by Application (2018-2029)
6.3 US & Canada Scopolamine Transdermal Patch Market Size by Country
6.3.1 US & Canada Scopolamine Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Scopolamine Transdermal Patch Sales by Country (2018-2029)
6.3.3 US & Canada Scopolamine Transdermal Patch Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Scopolamine Transdermal Patch Market Size by Type
7.1.1 Europe Scopolamine Transdermal Patch Sales by Type (2018-2029)
7.1.2 Europe Scopolamine Transdermal Patch Revenue by Type (2018-2029)
7.2 Europe Scopolamine Transdermal Patch Market Size by Application
7.2.1 Europe Scopolamine Transdermal Patch Sales by Application (2018-2029)
7.2.2 Europe Scopolamine Transdermal Patch Revenue by Application (2018-2029)
7.3 Europe Scopolamine Transdermal Patch Market Size by Country
7.3.1 Europe Scopolamine Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Scopolamine Transdermal Patch Sales by Country (2018-2029)
7.3.3 Europe Scopolamine Transdermal Patch Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Scopolamine Transdermal Patch Market Size
8.1.1 China Scopolamine Transdermal Patch Sales (2018-2029)
8.1.2 China Scopolamine Transdermal Patch Revenue (2018-2029)
8.2 China Scopolamine Transdermal Patch Market Size by Application
8.2.1 China Scopolamine Transdermal Patch Sales by Application (2018-2029)
8.2.2 China Scopolamine Transdermal Patch Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Scopolamine Transdermal Patch Market Size by Type
9.1.1 Asia Scopolamine Transdermal Patch Sales by Type (2018-2029)
9.1.2 Asia Scopolamine Transdermal Patch Revenue by Type (2018-2029)
9.2 Asia Scopolamine Transdermal Patch Market Size by Application
9.2.1 Asia Scopolamine Transdermal Patch Sales by Application (2018-2029)
9.2.2 Asia Scopolamine Transdermal Patch Revenue by Application (2018-2029)
9.3 Asia Scopolamine Transdermal Patch Sales by Region
9.3.1 Asia Scopolamine Transdermal Patch Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Scopolamine Transdermal Patch Revenue by Region (2018-2029)
9.3.3 Asia Scopolamine Transdermal Patch Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Scopolamine Transdermal Patch Market Size by Type
10.1.1 Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Scopolamine Transdermal Patch Market Size by Application
10.2.1 Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Country
10.3.1 Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Perrigo
11.1.1 Perrigo Company Information
11.1.2 Perrigo Overview
11.1.3 Perrigo Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Perrigo Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Perrigo Recent Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Overview
11.2.3 Baxter Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Baxter Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 GSK
11.3.1 GSK Company Information
11.3.2 GSK Overview
11.3.3 GSK Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 GSK Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GSK Recent Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Overview
11.4.3 Mylan Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Mylan Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Mylan Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Novartis Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 BengbuBBCATushan Pharmaceutical Co
11.6.1 BengbuBBCATushan Pharmaceutical Co Company Information
11.6.2 BengbuBBCATushan Pharmaceutical Co Overview
11.6.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 BengbuBBCATushan Pharmaceutical Co Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Scopolamine Transdermal Patch Industry Chain Analysis
12.2 Scopolamine Transdermal Patch Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Scopolamine Transdermal Patch Production Mode & Process
12.4 Scopolamine Transdermal Patch Sales and Marketing
12.4.1 Scopolamine Transdermal Patch Sales Channels
12.4.2 Scopolamine Transdermal Patch Distributors
12.5 Scopolamine Transdermal Patch Customers
13 Market Dynamics
13.1 Scopolamine Transdermal Patch Industry Trends
13.2 Scopolamine Transdermal Patch Market Drivers
13.3 Scopolamine Transdermal Patch Market Challenges
13.4 Scopolamine Transdermal Patch Market Restraints
14 Key Findings in The Global Scopolamine Transdermal Patch Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Scopolamine Transdermal Patch Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 1mg
Table 3. Major Manufacturers of 1.5mg
Table 4. Global Scopolamine Transdermal Patch Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Scopolamine Transdermal Patch Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Scopolamine Transdermal Patch Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Scopolamine Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Scopolamine Transdermal Patch Revenue Market Share by Region (2018-2024)
Table 9. Global Scopolamine Transdermal Patch Revenue Market Share by Region (2024-2029)
Table 10. Global Scopolamine Transdermal Patch Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Scopolamine Transdermal Patch Sales by Region (2018-2024) & (K Units)
Table 12. Global Scopolamine Transdermal Patch Sales by Region (2024-2029) & (K Units)
Table 13. Global Scopolamine Transdermal Patch Sales Market Share by Region (2018-2024)
Table 14. Global Scopolamine Transdermal Patch Sales Market Share by Region (2024-2029)
Table 15. Global Scopolamine Transdermal Patch Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Scopolamine Transdermal Patch Sales Share by Manufacturers (2018-2024)
Table 17. Global Scopolamine Transdermal Patch Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Scopolamine Transdermal Patch Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Scopolamine Transdermal Patch, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Scopolamine Transdermal Patch Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Scopolamine Transdermal Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Scopolamine Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Scopolamine Transdermal Patch as of 2022)
Table 23. Global Key Manufacturers of Scopolamine Transdermal Patch, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Scopolamine Transdermal Patch, Product Offered and Application
Table 25. Global Key Manufacturers of Scopolamine Transdermal Patch, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 28. Global Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 29. Global Scopolamine Transdermal Patch Sales Share by Type (2018-2024)
Table 30. Global Scopolamine Transdermal Patch Sales Share by Type (2024-2029)
Table 31. Global Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Scopolamine Transdermal Patch Revenue Share by Type (2018-2024)
Table 34. Global Scopolamine Transdermal Patch Revenue Share by Type (2024-2029)
Table 35. Scopolamine Transdermal Patch Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Scopolamine Transdermal Patch Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 38. Global Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 39. Global Scopolamine Transdermal Patch Sales Share by Application (2018-2024)
Table 40. Global Scopolamine Transdermal Patch Sales Share by Application (2024-2029)
Table 41. Global Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Scopolamine Transdermal Patch Revenue Share by Application (2018-2024)
Table 44. Global Scopolamine Transdermal Patch Revenue Share by Application (2024-2029)
Table 45. Scopolamine Transdermal Patch Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Scopolamine Transdermal Patch Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Scopolamine Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Scopolamine Transdermal Patch Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Scopolamine Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Scopolamine Transdermal Patch Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Scopolamine Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 60. Europe Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 61. Europe Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 62. Europe Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 65. Europe Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 66. Europe Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Scopolamine Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Scopolamine Transdermal Patch Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Scopolamine Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Scopolamine Transdermal Patch Sales by Country (2018-2024) & (K Units)
Table 72. Europe Scopolamine Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 73. China Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 74. China Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 75. China Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 78. China Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 79. China Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 82. Asia Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 83. Asia Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 86. Asia Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 87. Asia Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Scopolamine Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Scopolamine Transdermal Patch Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Scopolamine Transdermal Patch Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Scopolamine Transdermal Patch Sales by Region (2018-2024) & (K Units)
Table 93. Asia Scopolamine Transdermal Patch Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales by Country (2024-2029) & (K Units)
Table 107. Perrigo Company Information
Table 108. Perrigo Description and Major Businesses
Table 109. Perrigo Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Perrigo Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Perrigo Recent Developments
Table 112. Baxter Company Information
Table 113. Baxter Description and Major Businesses
Table 114. Baxter Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Baxter Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Baxter Recent Developments
Table 117. GSK Company Information
Table 118. GSK Description and Major Businesses
Table 119. GSK Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. GSK Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. GSK Recent Developments
Table 122. Mylan Company Information
Table 123. Mylan Description and Major Businesses
Table 124. Mylan Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Mylan Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Mylan Recent Developments
Table 127. Novartis Company Information
Table 128. Novartis Description and Major Businesses
Table 129. Novartis Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Novartis Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis Recent Developments
Table 132. BengbuBBCATushan Pharmaceutical Co Company Information
Table 133. BengbuBBCATushan Pharmaceutical Co Description and Major Businesses
Table 134. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. BengbuBBCATushan Pharmaceutical Co Recent Developments
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Scopolamine Transdermal Patch Distributors List
Table 140. Scopolamine Transdermal Patch Customers List
Table 141. Scopolamine Transdermal Patch Market Trends
Table 142. Scopolamine Transdermal Patch Market Drivers
Table 143. Scopolamine Transdermal Patch Market Challenges
Table 144. Scopolamine Transdermal Patch Market Restraints
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Scopolamine Transdermal Patch Product Picture
Figure 2. Global Scopolamine Transdermal Patch Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Scopolamine Transdermal Patch Market Share by Type in 2022 & 2029
Figure 4. 1mg Product Picture
Figure 5. 1.5mg Product Picture
Figure 6. Global Scopolamine Transdermal Patch Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Scopolamine Transdermal Patch Market Share by Application in 2022 & 2029
Figure 8. Motion Sickness
Figure 9. Nausea/Vomiting
Figure 10. Parkinsonian Tremor
Figure 11. Others
Figure 12. Scopolamine Transdermal Patch Report Years Considered
Figure 13. Global Scopolamine Transdermal Patch Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Scopolamine Transdermal Patch Revenue 2018-2029 (US$ Million)
Figure 15. Global Scopolamine Transdermal Patch Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Scopolamine Transdermal Patch Revenue Market Share by Region (2018-2029)
Figure 17. Global Scopolamine Transdermal Patch Sales 2018-2029 ((K Units)
Figure 18. Global Scopolamine Transdermal Patch Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Scopolamine Transdermal Patch Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Scopolamine Transdermal Patch Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Scopolamine Transdermal Patch Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Scopolamine Transdermal Patch Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Scopolamine Transdermal Patch Sales YoY (2018-2029) & (K Units)
Figure 24. China Scopolamine Transdermal Patch Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Scopolamine Transdermal Patch Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Scopolamine Transdermal Patch Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Scopolamine Transdermal Patch Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Scopolamine Transdermal Patch in the World: Market Share by Scopolamine Transdermal Patch Revenue in 2022
Figure 31. Global Scopolamine Transdermal Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 33. Global Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 34. Global Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 35. Global Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Scopolamine Transdermal Patch Revenue Share by Country (2018-2029)
Figure 41. US & Canada Scopolamine Transdermal Patch Sales Share by Country (2018-2029)
Figure 42. U.S. Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 45. Europe Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 46. Europe Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 47. Europe Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 48. Europe Scopolamine Transdermal Patch Revenue Share by Country (2018-2029)
Figure 49. Europe Scopolamine Transdermal Patch Sales Share by Country (2018-2029)
Figure 50. Germany Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 51. France Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 55. China Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 56. China Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 57. China Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 58. China Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 59. Asia Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 60. Asia Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 61. Asia Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 62. Asia Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 63. Asia Scopolamine Transdermal Patch Revenue Share by Region (2018-2029)
Figure 64. Asia Scopolamine Transdermal Patch Sales Share by Region (2018-2029)
Figure 65. Japan Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 69. India Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Scopolamine Transdermal Patch Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Scopolamine Transdermal Patch Sales Share by Country (2018-2029)
Figure 76. Brazil Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Scopolamine Transdermal Patch Revenue (2018-2029) & (US$ Million)
Figure 81. Scopolamine Transdermal Patch Value Chain
Figure 82. Scopolamine Transdermal Patch Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries